Innovent Biologics seeks to attract $422M in HK IPO

Note: This section contains information in English only.
Source: Dukascopy Bank SA
China's biotech company Innovent Biologics is seeking to attract $422M in its initial public offering in Hong Kong that could potentially be the largest biotech IPO in this year's financial hub.
Back to articles

Actual Topics

Mon, 15 Oct 2018 09:11:53 GMT

Kazatomprom likely to sell 25% stake in Astana/London IPO

The world's largest uranium producer Kazatomprom is likely to sell up to 25% of its stake in its planned London and Astana initial public offering.

Mon, 15 Oct 2018 08:28:25 GMT

Geencore sells its US business in $1.0B deal

On Monday, Britain's biggest sandwich maker Greencore Group announced about the sale of its US business in a $1.0B deal.

Subscribe to "Fundamental Analysis" feed

Subscribe
Pre viac informácií o Dukascopy Bank CFD / Forex obchodných platformách a ostatných záležitostiach
nás prosím kontaktujte alebo požiadajte o hovor od nás.
For further information regarding potential cooperation,
please call us or make callback request.
To learn more about Dukascopy Bank Binary Options / Forex trading platform, SWFX and other trading related information,
please call us or make callback request.
Pre viac informácií o Dukascopy Bank CFD / Forex obchodných platformách a ostatných záležitostiach
nás prosím kontaktujte alebo požiadajte o hovor od nás.
To learn more about Crypto Trading / CFD / Forex trading platform, SWFX and other trading related information,
please call us or make callback request.
To learn more about Business Introducer and other trading related information,
please call us or make callback request.
For further information regarding potential cooperation,
please call us or make callback request.